| Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism A Wahlström, SI Sayin, HU Marschall, F Bäckhed Cell metabolism 24 (1), 41-50, 2016 | 2369 | 2016 |
| Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist SI Sayin, A Wahlström, J Felin, S Jäntti, HU Marschall, K Bamberg, ... Cell metabolism 17 (2), 225-235, 2013 | 2326 | 2013 |
| The gut microbiota modulates host energy and lipid metabolism in mice [S] VR Velagapudi, R Hezaveh, CS Reigstad, P Gopalacharyulu, L Yetukuri, ... Journal of lipid research 51 (5), 1101-1112, 2010 | 699 | 2010 |
| Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells MS Trabelsi, M Daoudi, J Prawitt, S Ducastel, V Touche, SI Sayin, ... Nature communications 6 (1), 7629, 2015 | 389 | 2015 |
| Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 6: 6528 Q Feng, S Liang, H Jia, A Stadlmayr, L Tang, Z Lan, D Zhang, H Xia, X Xu, ... | 73 | 2015 |
| Targeting Zfp148 activates p53 and reduces tumor initiation in the gut A Nilton, VI Sayin, ZV Zou, SI Sayin, C Bondjers, N Gul, P Agren, ... Oncotarget 7 (35), 56183, 2016 | 14 | 2016 |
| Aging promotes lung cancer metastasis through epigenetic ATF4 induction AAH Patel, J Dzanan, KX Ali, EA Eklund, SW Alvarez, I Altinönder, D Raj, ... bioRxiv, 2024.07. 03.601209, 2024 | | 2024 |
| Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis EA Eklund, A Mourad, C Wiel, SI Sayin, H Fagman, A Hallqvist, VI Sayin Frontiers in Oncology 14, 2024 | | 2024 |
| Equalizing prognostic disparities in stage III KRAS-mutant NSCLC: addition of durvalumab to combined chemoradiotherapy improves survival EA Eklund, M Orgard, D Wallin, SI Sayin, H Fagman, S Raghavan, ... medRxiv, 2024.03. 21.24304669, 2024 | | 2024 |
| KRAS mutations in combination with primary tumor size are not associated with a worse prognosis in early Non-Small Cell Lung Cancer EA Eklund, A Mourad, C Wiel, H Fagman, A Hallqvist, VI Sayin medRxiv, 2023.05. 02.23289316, 2023 | | 2023 |
| Gut microbial regulation of bile acid metabolism and signaling S Sayin | | 2016 |
| Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L-cells S Lestavel, MS Trabelsi, M Daoudi, S Ducastel, V Touche, O Briand, ... Diabetologia 58, S272-S272, 2015 | | 2015 |
Matej OrešičProfessor of Medicine (Systems Medicine), Örebro University & University of Turku在 oru.se 的电子邮件经过验证
Matej OrešičProfessor of Medicine (Systems Medicine), Örebro University & University of Turku在 oru.se 的电子邮件经过验证
Sirkku JänttiSr. Scientist在 helsinki.fi 的电子邮件经过验证